☆ 4.5 Article

The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE

HPB (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

A. Cervantes et al.

ANNALS OF ONCOLOGY (2023)

Add to Collection

Review Oncology

A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer

Constantinos Simillis et al.

Summary: This systematic literature review investigated and compared the neoadjuvant therapy strategies for stage II and III rectal cancer. The study found that conventional neoadjuvant therapies with short-course radiation or long-course chemoradiotherapy have oncological benefits without increasing perioperative complication rates. Prolonged wait to surgery may improve oncological outcomes. Total neoadjuvant therapies provide additional benefits in terms of complete response, positive resection margins, and disease-free survival. Monoclonal antibody therapy may further improve oncological outcomes but currently is only applicable to a small subgroup of patients and requires further validation.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2023)

Add to Collection

Article Oncology

Treatment of Metastatic Colorectal Cancer: ASCO Guideline

Van K. Morris et al.

Summary: The purpose of this study is to develop treatment recommendations for patients with metastatic colorectal cancer (mCRC). An Expert Panel convened by ASCO conducted a systematic review of relevant studies and developed recommendations for clinical practice. Based on the inclusion criteria, five systematic reviews and ten randomized controlled trials were included in the analysis. The recommendations include offering doublet chemotherapy or triplet therapy to previously untreated mCRC patients who are initially unresectable, based on studies of chemotherapy combined with anti-vascular endothelial growth factor antibodies. Pembrolizumab is recommended for first-line treatment of mCRC patients with microsatellite instability-high or deficient mismatch repair tumors. Chemotherapy and anti-epidermal growth factor receptor therapy are recommended for microsatellite stable or proficient mismatch repair left-sided treatment-naive RAS wild-type mCRC, while chemotherapy and anti-vascular endothelial growth factor therapy are recommended for microsatellite stable or proficient mismatch repair RAS wild-type right-sided mCRC. Encorafenib plus cetuximab is recommended for previously treated BRAF V600E-mutant mCRC patients who have progressed after one previous line of therapy. Other recommendations are provided for patients with colorectal peritoneal metastases, liver metastases, and candidates for potentially curative resection of liver metastases. Multidisciplinary team management and shared decision making are also recommended.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Add to Collection

Review Surgery

Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations 2022

Gaetan-Romain Joliat et al.

Summary: The present study aimed to update the ERAS guidelines in liver surgery using a modified Delphi method based on a systematic review of the literature. A total of 25 recommendation items were elaborated, which obtained consensus from international experts. These guidelines allow standardization of the perioperative management of patients undergoing liver surgery.

WORLD JOURNAL OF SURGERY (2023)

Add to Collection

Article Gastroenterology & Hepatology

A comparison of the simultaneous, liver-first, and colorectal-first strategies for surgical treatment of synchronous colorectal liver metastases at two major liver-surgery institutions in Sweden

Petter Fruhling et al.

Summary: This study compared the outcome of simultaneous, liver-first, and colorectal-first surgical approaches for patients with synchronous colorectal liver metastases. The results showed that there were no significant differences in overall survival and postoperative complications between the simultaneous and liver-first approaches.

HPB (2023)

Add to Collection

Article Oncology

Determinants of Pre-Surgical Treatment in Primary Rectal Cancer: A Population-Based Study

Israa Imam et al.

Summary: Preoperative radiotherapy plays a role in rectal cancer treatment, but its usage varies significantly. MRI characteristics are crucial in treatment selection, along with patient-related factors. However, the accuracy of MRI evaluation is poor, and the use of radiation has decreased over time.

CANCERS (2023)

Add to Collection

Review Surgery

Colonic stenting for malignant obstructions-A review of current indications and outcomes

Amelie Lueders et al.

Summary: Colonic stenting is the preferred palliative treatment for left sided malignant obstructions, which can shorten hospital stays, decrease healthcare cost, reduce permanent stoma rates, and expedite the start of chemotherapy. However, its role as a bridge-to-surgery remains uncertain. Stenting carries certain risks, including the risk of technical or clinical failure and the complications that may arise from perforations.

AMERICAN JOURNAL OF SURGERY (2022)

Add to Collection

Article Oncology

Management of Colorectal Cancer with Synchronous Liver Metastases: An Inception Cohort Study (CoSMIC)

Anthony K. C. Chan et al.

Summary: The study recruited 125 patients with colorectal cancer and synchronous liver metastases, showing equivalent perioperative complications and healthcare occupancy outcomes between patients completing staged and synchronous pathways. Future research should focus on optimizing pathway selection criteria, integrating cancer genomics data, and considering patient preferences.

ANNALS OF SURGICAL ONCOLOGY (2022)

Add to Collection

Review Oncology

Current State of Neoadjuvant Radiotherapy for Rectal Cancer

Sweet Ping Ng et al.

Summary: Colorectal cancer, particularly rectal cancer, is a common diagnosis with risks of local recurrence and distant metastasis. Research into new treatment sequencing and regimens is ongoing to improve outcomes for patients with locally advanced rectal adenocarcinoma.

CLINICAL COLORECTAL CANCER (2022)

Add to Collection

Article Gastroenterology & Hepatology

Tumour genotypes account for survival differences in right- and left-sided colon cancers

Thomas M. Ward et al.

Summary: This study aimed to identify genetic differences between right- and left-sided colon cancers and explained the lower survival in right-sided cancers. The results showed that mutated alleles differed significantly between the two tumor sites, and identified several genes with a significant impact on survival.

COLORECTAL DISEASE (2022)

Add to Collection

Article Oncology

Colorectal cancer and synchronous liver metastases: An individual case-based qualitative study (CoSMIC-Q)

Anthony KC. Chan et al.

Summary: This qualitative study explores the experiences and views of patients and clinicians in the management of colorectal cancer with synchronous liver metastases. The study reveals that patients value their first consultation and perceive a sufficient level of autonomy in decision making. Patients generally prefer synchronous surgery but understand the associated risks. Clinicians acknowledge limited evidence for decision making and consider trials of treatment sequencing unfeasible.

EJSO (2022)

Add to Collection

Article Oncology

Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases

Koichiro Yoshino et al.

Summary: Postoperative and post-adjuvant chemotherapy CEA levels > 5 ng/ml may serve as predictors of recurrence-free survival (RFS) and overall survival (OS) in patients with colorectal cancer and liver metastasis (CLM).

ANNALS OF SURGICAL ONCOLOGY (2022)

Add to Collection

Review Immunology

Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review

Wei-Jian Mei et al.

Summary: Colorectal cancers with high microsatellite instability and deficient mismatch repair have different characteristics compared to normal CRC, but the testing rates for MSI and MMR remain low in clinical practice. Insufficient testing fails to identify patients with these types of CRC who could benefit from immunotherapy. Understanding the importance of MMR/MSI status in the clinical characteristics and prognosis of CRC may help improve testing rates and guide the development of more effective therapies.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Update on MR Contrast Agents for Liver Imaging What to Use and When

Ashley Kalor et al.

Summary: This article discusses the gadolinium-based contrast agent, extracellular contrast agent, hepatobiliary agent, and their applications in hepatobiliary phase magnetic resonance imaging, as well as the research on hepatobiliary excretion and metastasis.

RADIOLOGIC CLINICS OF NORTH AMERICA (2022)

Add to Collection

Article Surgery

Predictors of Liver Failure in Non-Cirrhotic Patients Undergoing Hepatectomy

Gabriel Orozco et al.

Summary: Post-hepatectomy liver failure (PHLF) in non-cirrhotic patients increases the risk of perioperative mortality and is associated with the extent of hepatectomy and infectious complications.

WORLD JOURNAL OF SURGERY (2022)

Add to Collection

Article Oncology

Impact of Preoperative Chemotherapy Features on Patient Outcomes after Hepatectomy for Initially Unresectable Colorectal Cancer Liver Metastases: A LiverMetSurvey Analysis

Pasquale F. Innominato et al.

Summary: This study investigated the impact of preoperative systemic anticancer therapy (PO-SACT) features on outcomes in patients with initially-irresectable colorectal liver metastases (CLM). The results showed that a shorter duration of PO-SACT was associated with longer overall survival, regardless of other prognostic factors. The study also supported the recommendation of performing liver surgery as soon as possible after response to PO-SACT in patients with initially irresectable CLM. The choice of PO-SACT regimen had little or no impact on outcomes when resection was achieved.

CANCERS (2022)

Add to Collection

Review Oncology

The evolving treatment paradigm of locally advanced rectal cancer: a narrative review

Muhammad Awawda et al.

Summary: This review discusses the treatment evolution of locally advanced rectal cancer (LARC) and highlights the key differences between different strategies. Based on current evidence, distinct patient subgroups are defined and a treatment algorithm is proposed to match their risk.

JOURNAL OF GASTROINTESTINAL ONCOLOGY (2022)

Add to Collection

Article Oncology

Safety and Efficacy of Palliative Radiotherapy (25 Gy x 5 Fractions) for Symptomatic Pelvic Tumors

Tomomi Aoshika et al.

Summary: This study retrospectively evaluated the safety and efficacy of palliative radiotherapy (RT) for symptomatic pelvic tumors when delivered as 25 Gy in 5 fractions. The results showed that this treatment method is safe and effective for symptomatic pelvic tumors, with hemostatic and pain relief effects.

ANTICANCER RESEARCH (2022)

Add to Collection

Review Surgery

The role of liver surgery in simultaneous synchronous colorectal liver metastases and colorectal cancer resections: a literature review of 1730 patients underwent open and minimally invasive surgery

Pasquale Avella et al.

Summary: Colorectal cancer (CRC) is a common malignant neoplastic disease, with approximately 25-35% of patients developing liver metastasis. This study found through a literature review that minimally invasive surgery has peri-operative advantages and may be the preferred treatment for patients with simultaneous liver metastasis and CRC.

MINERVA SURGERY (2022)

Add to Collection

Review Health Care Sciences & Services

Disappearing Colorectal Liver Metastases: Do We Really Need a Ghostbuster?

Alessandro Anselmo et al.

Summary: The development of new systemic treatment strategies has significantly improved the response rates of colorectal liver metastases (CRLM) in recent years. However, the complete shrinkage of liver metastases (DLM) presents a therapeutic dilemma and proper management is still debated. DLM does not necessarily mean cure, as pathological examination often reveals residual disease or early recurrence. A multidisciplinary approach, particularly involving radiologists, is needed to assist surgeons in managing DLM.

HEALTHCARE (2022)

Add to Collection

Article Surgery

Synchronous resection of primary colorectal cancer with liver metastases: two birds with one stone?

Ajith K. Siriwardena

BRITISH JOURNAL OF SURGERY (2022)

Add to Collection

Review Surgery

Colonic stenting for malignant obstructions-A review of current indications and outcomes

Amelie Lueders et al.

Summary: Colonic stenting is an effective palliative treatment for left-sided malignant obstructions, but its role and risks as a bridge-to-surgery remain controversial. Preventive stent placement may increase the risk of intestinal obstruction development, with a significant failure rate of 25% in technical or clinical aspects. Perforations may lead to higher rates of local recurrence and mortality.

AMERICAN JOURNAL OF SURGERY (2022)

Add to Collection

Article Surgery

Simultaneous Versus Delayed Resection for Initially Resectable Synchronous Colorectal Cancer Liver Metastases A Prospective, Open-label, Randomized, Controlled Trial

Karim Boudjema et al.

Summary: This study compared simultaneous resection and delayed resection of synchronous colorectal cancer liver metastases, finding no significant difference in the rate of major complications between the two groups. However, delayed resection tended to impair overall survival.

ANNALS OF SURGERY (2021)

Add to Collection

Article Oncology

Hepatectomy risk assessment with functional magnetic resonance imaging (HEPARIM)

Mohamed Elsharif et al.

Summary: The HEPARIM trial aims to predict post hepatectomy liver failure risk more accurately using MRI biomarkers. The study utilizes an observational cohort design and multivariate analysis to derive prediction models for safer surgical decisions for patients.

BMC CANCER (2021)

Add to Collection

Editorial Material Surgery

Proposal of a New Comprehensive Notation for Hepatectomy The New World'' Terminology

Masato Nagino et al.

ANNALS OF SURGERY (2021)

Add to Collection

Article Oncology

Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial

Yukihide Kanemitsu et al.

Summary: This study investigated whether primary tumor resection (PTR) before chemotherapy improves survival in patients with colorectal cancer (CRC) with asymptomatic primary tumor and synchronous unresectable metastases. The results showed that PTR followed by chemotherapy did not provide a survival benefit over chemotherapy alone for CRC patients with asymptomatic primary tumors and synchronous unresectable metastases.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Add to Collection

Article Surgery

Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment The CAIRO4 Phase 3 Randomized Clinical Trial

Dave E. W. van der Kruijssen et al.

Summary: The study aimed to determine the difference in 60-day mortality between mCRC patients receiving systemic treatment only vs PTR followed by systemic treatment, and to identify risk factors associated with 60-day mortality. The results showed that patients randomized to PTR had a higher 60-day mortality, especially those with elevated serum levels of certain markers.

JAMA SURGERY (2021)

Add to Collection

Article Oncology

Management of obstructive colon cancer: Current status, obstacles, and future directions

Ri-Na Yoo et al.

Summary: Approximately 10%-18% of colon cancer patients present with obstruction at initial diagnosis. Emergency surgery has traditionally been the indicated treatment, but patients requiring it have higher morbidity and mortality rates. The use of self-expandable metal stents (SEMS) is growing, but controversies exist regarding their application in potentially curable diseases.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)

Add to Collection

Article Oncology

Liver-First Approach for Synchronous Colorectal Metastases: Analysis of 7360 Patients from the LiverMetSurvey Registry

Felice Giuliante et al.

Summary: In patients with synchronous CRLM, the liver-first approach should be considered for those with multiple bilobar metastases, as it has been associated with longer survival compared to alternative approaches. The surgical strategy should be tailored based on the hepatic tumor burden.

ANNALS OF SURGICAL ONCOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Diagnosis and management of acute lower gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Konstantinos Triantafyllou et al.

ENDOSCOPY (2021)

Add to Collection

Review Gastroenterology & Hepatology

Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines

Glenn K. Bonney et al.

Summary: Colorectal cancer is a prevalent disease worldwide, with high rates of liver metastases. The current trend in treating non-resectable colorectal liver metastases leans towards liver transplantation, requiring interdisciplinary expertise, research, and ethics considerations. It is important to take into account the impact of liver transplantation on resource allocation and national transplant waiting lists.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

A meta-analysis of liver-first versus classical strategy for synchronous colorectal liver metastases

Dimitrios E. Magouliotis et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2020)

Add to Collection

Article Oncology

Biplane transrectal ultrasonography plus ultrasonic elastosonography and contrast-enhanced ultrasonography in T staging of rectal cancer

Yanru Feng et al.

BMC CANCER (2020)

Add to Collection

Article Gastroenterology & Hepatology

Use of a modified Delphi approach to develop research priorities in HPB surgery across the United Kingdom

Stephen R. Knight et al.

HPB (2019)

Add to Collection

Article Oncology

SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)

M. A. Gomez-Espana et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2019)

Add to Collection

Article Oncology

Synchronous and metachronous liver metastases in patients with colorectal cancer-towards a clinically relevant definition

Jennie Engstrand et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)

Add to Collection

Article Oncology

Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

Kaitlyn K. H. Goey et al.

EUROPEAN JOURNAL OF CANCER (2018)

Add to Collection

Article Medicine, General & Internal

Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study

Maxime J. M. van der Valk et al.

LANCET (2018)

Add to Collection

Article Surgery

Primary Tumor Versus Liver-First Approach for Synchronous Colorectal Liver Metastases: An Association Francaise de Chirurgie (AFC) Multicenter-Based Study with Propensity Score Analysis

Francesco Esposito et al.

WORLD JOURNAL OF SURGERY (2018)

Add to Collection

Article Multidisciplinary Sciences

Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis

Sean P. Pitroda et al.

NATURE COMMUNICATIONS (2018)

Add to Collection

Article Oncology

Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial

Robbert S. Puijk et al.

BMC CANCER (2018)

Add to Collection

Article Surgery

The Southampton Consensus Guidelines for Laparoscopic Liver Surgery From Indication to Implementation

Mohammad Abu Hilal et al.

ANNALS OF SURGERY (2018)

Add to Collection

Article Oncology

Resection of colorectal liver metastases after second-line chemotherapy: is it worthwhile? A LiverMetSurvey analysis of 6415 patients

Rene Adam et al.

EUROPEAN JOURNAL OF CANCER (2017)

Add to Collection

Letter Gastroenterology & Hepatology

Watch-and-wait approach for rectal cancer: concepts of a subject-specific method

Andrew G. Renehan et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Improving definition of the term synchronous liver metastases from colorectal cancer

Anthony K. C. Chan et al.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2016)

Add to Collection

Review Oncology

Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus

Rene Adam et al.

CANCER TREATMENT REVIEWS (2015)

Add to Collection

Article Oncology

Role of Neoadjuvant Chemotherapy in Resectable Synchronous Colorectal Liver Metastasis; an International Multi-Center Data Analysis Using Livermetsurvey

Glenn K. Bonney et al.

JOURNAL OF SURGICAL ONCOLOGY (2015)

Add to Collection

Article Biochemistry & Molecular Biology

The consensus molecular subtypes of colorectal cancer

Justin Guinney et al.

NATURE MEDICINE (2015)

Add to Collection

Review Gastroenterology & Hepatology

Treatment strategies for colorectal carcinoma with synchronous liver metastases: Which way to go?

Peter Ihnat et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Add to Collection

Article Gastroenterology & Hepatology

Disappearing liver metastases from colorectal cancer: impact of modern imaging modalities

Christian Sturesson et al.

HPB (2015)

Add to Collection

Article Medicine, General & Internal

Effect of PET Before Liver Resection on Surgical Management for Colorectal Adenocarcinoma Metastases A Randomized Clinical Trial

Carol-Anne Moulton et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Add to Collection

Review Oncology

Management of colorectal cancer presenting with synchronous liver metastases

Ajith K. Siriwardena et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2014)

Add to Collection

Review Surgery

The Liver-First Approach to the Management of Colorectal Cancer With Synchronous Hepatic Metastases A Systematic Review

Santhalingam Jegatheeswaran et al.

JAMA SURGERY (2013)

Add to Collection

Article Surgery

Effect of specialist decision-making on treatment strategies for colorectal liver metastases

R. P. Jones et al.

BRITISH JOURNAL OF SURGERY (2012)

Add to Collection

Article Surgery

Cardiopulmonary exercise testing for preoperative risk assessment before hepatic resection

M. A. Junejo et al.

BRITISH JOURNAL OF SURGERY (2012)

Add to Collection

Article Surgery

The Levels of Evidence and Their Role in Evidence-Based Medicine

Patricia B. Burns et al.

PLASTIC AND RECONSTRUCTIVE SURGERY (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.